Edition:
United States

Selecta Biosciences Inc (SELB.OQ)

SELB.OQ on NASDAQ Stock Exchange Global Market

10.01USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$10.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,812
52-wk High
$24.00
52-wk Low
$8.70

Select another date:

Tue, Nov 7 2017

BRIEF-Selecta Biosciences announces Q3 loss per share $0.66

* Selecta Biosciences announces third quarter 2017 financial results and provides corporate update

BRIEF-Selecta Biosciences names John Leaman chief financial officer

* Selecta Biosciences announces important additions to senior leadership team

Deals of the day-Mergers and acquisitions

Aug 25 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

South Korea's CJ buys Brazil soy protein maker from Chile's Corpesca

SAO PAULO Brazilian soy protein maker Selecta said its owners had sold a 90 percent stake to South Korea's CJ CheilJedang Corp for 450 million reais ($143 million).

South Korea's CJ buys Brazil soy protein maker from Chile's Corpesca

SAO PAULO, Aug 25 Brazilian soy protein maker Selecta said its owners had sold a 90 percent stake to South Korea's CJ CheilJedang Corp for 450 million reais ($143 million).

EU clears Selecta's purchase of Dutch Pelican Rouge

BRUSSELS, Aug 25 EU antitrust regulators cleared Swiss vending services provider Selecta's proposed acquisition of Dutch peer Pelican Rouge, subject to the divestment of all Selecta's vending service activities in Finland.

EU mergers and takeovers (Aug 24)

BRUSSELS, Aug 23 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

BRIEF-Selecta Biosciences files for mixed shelf of up to $‍​200 mln - SEC Filing

* Selecta Biosciences Inc files for mixed shelf of up to $‍​200 million - SEC Filing Source text: [http://bit.ly/2vpzRSi] Further company coverage:

BRIEF-Selecta Biosciences Q2 loss per share $0.85

* Selecta biosciences announces second quarter 2017 financial results and provides corporate update

BRIEF-Selecta Biosciences files for offering of 3.2 mln shares by selling stockholders

* Selecta Biosciences files shelf prospectus relating to proposed offering and resale of 3.2 million shares of common stock by selling stockholders - SEC filing Source text: (http://bit.ly/2vfRh0F) Further company coverage:

Select another date: